ERBB2 and triple-negative breast carcinoma: Besides MCF-7 cells, the effect of equol was also measured in ErbB2 positive cells (MDA-MB-453) and triple-negative breast cancer (TNBC) cell lines (ER-, PR-, ErbB2-), which are MDA-MB-468, MDA-MB-231, and HS578t.